Policy | March 12, 2022
Govt earmarks Rs 500 crore for pharma clusters and MSMEs
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers releases guidelines for the scheme
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
Data from this study will support a submission to expand the use of atogepant to include preventive treatment of chronic migraine in the United States and additional submissions globally
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
Selvax's goal is to develop safe, effective and immunological-based treatments for a range of hard-to-treat solid tumours
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Breakthrough formulation helps reduce the risk of exposure using a non-hazardous formulation and leakproof format during transport and processing
Alvotech expects AVT02 (adalimumab) will be marketed in the U.S., subject to regulatory approval, on July 1, 2023
Nulibry is approved by the U.S. Food and Drug Administration (USFDA) to reduce the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A, an ultra-rare, life-threatening paediatric genetic disorder
Under this year’s theme of ‘Kidney Health For All’, ISN along with AstraZeneca aims to generate large scale awareness and educate people about ways to improve kidney health
Subscribe To Our Newsletter & Stay Updated
